Skip to main content

SDGs

Goal Specific efforts Website Page
ASKA HD REPORT Annual Securities Report ESG Chart and ESG Data Book
3. Good health and well-being
  • A wide variety of hormonal products in the field of obstetrics and gynecology
  • Pharmaceuticals for the treatment of hepatic encephalopathy, a rare disease
  • Thyroid hormone preparations that have been used for about 100 years
  • Highly accurate LC-MS/MS sample measurement using proprietary technology
  • Health management
P9-P10 P17-P18 P24-P44


P12-P13 P19-P23 P25-P26
5. Gender equality
  • Oral and emergency contraceptives
  • Uterine fibroids and endometriosis agent
  • Dysmenorrhea agent
  • Fertility Agents
  • Eclampsia control and agent
  • Highly accurate steroid hormone measurement for preventive medicine and improvement of unwellness
  • Location-specific medical representative system
  • Telecommuting system
  • Granting of annual leave in increments of hours
  • Introduced pioneering hourly "child nursing care leave and nursing care leave" program
  • Paid childcare leave
  • Target for male employees taking childcare leave: 100%
P5-P10 P17-P30

P16-P19 P16-P19
7. Affordable and clean energy
  • Promote energy conservation activities
  • Reduction of greenhouse gas emissions (conversion from heavy oil to city gas)
  • Establishment and operation of environmental management systems, etc.
  • Reduce unit energy consumption of all group companies by 1% or more compared to the previous year
P49-P52
P14-P16 P2-P14
12. Responsible consumption and production
  • Ensure appropriate inventory by utilizing our own factories, contract manufacturers, and external warehouses
  • Operation of quality systems in pharmaceuticals (management review with management participation)
  • Steady implementation of risk management plans for ethical pharmaceuticals, etc.
P5-P10 P17-P32 P37-P48



P14-P16 P1-P33

13. Climate action
  • Promote energy conservation activities
  • Reduction of greenhouse gas emissions (conversion from heavy oil to city gas)
  • Establishment and operation of environmental management systems, etc.
  • Reduce unit energy consumption of all group companies by 1% or more compared to the previous year
P17-P18 P27-P28 P49-P52
P13-P16 P2-P14
14. Life below water
  • A wide variety of reproductive hormones
  • Oxytocin Injection Solution for Veterinary Use
  • Mixed feed (Best Balance Series), etc.
P17-P18 P27-P28 P49-P52

P13-P16 P2-P14
15. Life on land
  • A wide variety of reproductive hormones
  • Oxytocin Injection Solution for Veterinary Use
  • Mixed feed (Best Balance Series), etc.
P17-P18 P27-P28 P49-P52

P13-P16 P2-P14
16. Peace justice and strong institutions
  • Ensure substantial equality of shareholders
  • Fostering a corporate culture and climate that respects sound business ethics
  • Ensuring Transparency
  • Effective supervision of directors
  • Constructive dialogue with shareholders
P17-P18 P27-P30 P69-P76

P13-P16 P27-P33
17. Partnerships for the goals
  • Enhancement of Testing Technology and Drug Discovery Functions in Shonan iPark through Collaboration with Other Companies
  • Addition of pediatric dosage and indication for existing pharmaceuticals, etc.
  • Veterinary pharmaceuticals developed from ethical pharmaceuticals
P17-P18 P27-P30 P36-P48

P5-P13 P23-P26 P33